{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:43:07Z","timestamp":1779907387561,"version":"3.53.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005747","name":"A.P. M\u00f8ller og Hustru Chastine Mc-Kinney M\u00f8llers Fond til almene Formaal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R219 - 2016 - 270"],"award-info":[{"award-number":["R219 - 2016 - 270"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF14OC0008847"],"award-info":[{"award-number":["NNF14OC0008847"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijcard.2018.06.110","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T09:58:37Z","timestamp":1532944717000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Concomitant use of statins and macrolide antibiotics and risk of serious renal events: A nationwide cohort study"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7417-8889","authenticated-orcid":false,"given":"Marie","family":"Lund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Svanstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-8466","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.06.110_bb0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.2013.284657","article-title":"More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines","volume":"311","author":"Ioannidis","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0010","first-page":"58","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres","year":"2015","journal-title":"Ochsner J."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0015","unstructured":"L\u00e6gemiddelstyrelsen (Danish Medicines Agency), Summary of Product Characteristics Simvastatin \u201cAurobindo\u201d, (version updated November 4, 2016)."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0020","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(04)16513-6","article-title":"Dangers of rosuvastatin identified before and after FDA approval","volume":"363","author":"Wolfe","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0025","series-title":"Information for Healthcare Professionals: Crestor (Rosuvastatin Calcium)","author":"US Food and Drug Administration","year":"2005"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0030","doi-asserted-by":"crossref","first-page":"f880","DOI":"10.1136\/bmj.f880","article-title":"Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases","volume":"346","author":"Dormuth","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0035","doi-asserted-by":"crossref","first-page":"c2197","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database","volume":"340","author":"Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/imj.12464","article-title":"Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin","volume":"44","author":"Page","year":"2014","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/108729103321655854","article-title":"Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir\/ritonavir in a patient with HIV","volume":"17","author":"Mah Ming","year":"2003","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0055","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00003072-200412000-00008","article-title":"Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy","volume":"29","author":"Trieu","year":"2004","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0060","first-page":"213","article-title":"Rhabdomyolysis associated with lovastatin and erythromycin use","volume":"154","author":"Spach","year":"1991","journal-title":"West. J. Med."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/ageing\/afm110","article-title":"A cautionary tale: delayed onset rhabdomyolysis due to erythromycin\/simvastatin interaction","volume":"36","author":"Campbell","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0070","series-title":"FDA Drug Safety Communication: Interactions between Certain HIV or Hepatitis C Drugs and Cholesterol-Lowering Statin Drugs Can Increase the Risk of Muscle Injury","author":"U.S. Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-158-12-201306180-00004","article-title":"Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study","volume":"158","author":"Patel","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0080","unstructured":"Promedicin, \u201cSurlid\u201d, \u201cVepicombin Novum\u201d, \u201cAbboticin\u201d, \u201cKlacid\u201d, [cited 2018 May 25]. Available from:www.pro.medicin.dk."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0085","series-title":"Guidance for Industry Drug Interaction Studies \u2014 Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations. Draft Guidance","author":"US Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","article-title":"The challenge of managing drug interactions in elderly people","volume":"370","author":"Mallet","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Public Health."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand. J. Public Health."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand. J. Public Health."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0110","article-title":"Acute kidney injury","volume":"67","author":"Levey","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pds.2308","article-title":"Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population","volume":"21","author":"Bakhai","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacl.2008.10.007","article-title":"Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases","volume":"2","author":"Ming","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2125.2008.03345.x","article-title":"Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy","volume":"67","author":"Devold","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0130","article-title":"Co-medication of statins with contraindicated drugs","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2018.06.110_bb0135","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.amjcard.2004.07.080","article-title":"Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors","volume":"94","author":"Jacobson","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/009127009903900510","article-title":"Erythromycin coadministration increases plasma atorvastatin concentrations","volume":"39","author":"Siedlik","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9236(98)90151-5","article-title":"Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations","volume":"64","author":"Kantola","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00228-001-0385-6","article-title":"Effect of roxithromycin on the pharmacokinetics of lovastatin in volunteers","volume":"57","author":"Bucher","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0155","unstructured":"L\u00e6gemiddelstyrelsen (Danish Medicines Agency), Summary of Product Characteristics Lovastatin \u201cStada\u201d, (version updated March 10, 2016)."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0160","unstructured":"L\u00e6gemiddelstyrelsen (Danish Medicines Agency), Summary of Product Characteristics Atorvastatin \u201cMylan\u201d, (version updated March 23, 2017)."},{"key":"10.1016\/j.ijcard.2018.06.110_bb0165","unstructured":"Sundhedsstyrelsen (Danish Health and Medicines Authority), Summary of Product Characteristics Surlid, (version updated April 22, 2015)."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318334259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318334259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:39:18Z","timestamp":1759091958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318334259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"alternative-id":["S0167527318334259"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.110","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant use of statins and macrolide antibiotics and risk of serious renal events: A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}